Suppr超能文献

新型人丝氨酸蛋白酶抑制剂博马平(bomapin)在正常/恶性造血过程以及单核细胞系THP-1和AML-193中的表达。

Expression of bomapin, a novel human serpin, in normal/malignant hematopoiesis and in the monocytic cell lines THP-1 and AML-193.

作者信息

Riewald M, Chuang T, Neubauer A, Riess H, Schleef R R

机构信息

Department of Vascular Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.

出版信息

Blood. 1998 Feb 15;91(4):1256-62.

PMID:9454755
Abstract

Our group recently cloned the cDNA-encoding bomapin, a member of the serine protease inhibitor (serpin) superfamily, from a human bone marrow cDNA library (J Biol Chem 270:2675, 1995). To understand its expression within the hematopoietic compartment, RNA extracted from bone marrow or peripheral blood from normal donors and patients with leukemia was reverse transcribed and analyzed by polymerase chain reaction (PCR). Bomapin PCR products were readily detected in normal bone marrow, which was designated as a medium mRNA level. In peripheral blood, bomapin expression was low or undetectable in normal donors (n = 6) and patients with chronic lymphocytic leukemia (n = 6). Blood from patients with chronic myeloid leukemia (n = 6), chronic myelomonocytic leukemia (n = 6), acute myeloid leukemia (n = 5), and acute lymphocytic leukemia (n = 5) exhibited low to medium levels of bomapin expression. Furthermore, a high level of bomapin expression was detected in one individual with acute monocytic leukemia. These data suggest that bomapin expression may be elevated in hematopoietic cells of monocytic lineage. Therefore, we analyzed the expression of bomapin within cell lines that exhibited characteristics of the monocytic lineage. Bomapin PCR products were detected in the monocytic THP-1 and AML-193 cell lines but not in CRL 7607, CRL 7541, KG-1, or K562 cells. Induction of bomapin transcripts was not detected in the latter series of cell lines following a 24-hour treatment with phorbol myristate acetate (PMA, 10(-8) mol/L) or tumor necrosis factor-alpha (TNF-alpha, 30 U/mL), whereas treatment of THP-1 or AML-193 cells with these agents reduced the intensity of the bomapin PCR products. Northern blotting confirmed these results and showed that the expression of bomapin in THP-1 cells was downregulated over a 4-day period by PMA and, to a lesser extent, TNF-alpha. Immunoblotting was used to show the presence of a 40-kD protein in THP-1 cytosol preparations. Bomapin antigen levels were correspondingly reduced after treatment with PMA. Because PMA and TNF-alpha induce monocytic differentiation in THP-1 and AML-193 cells, these data increase the possibility that bomapin may play a role in the regulation of protease activities specifically in early stages of cellular differentiation.

摘要

我们小组最近从人骨髓cDNA文库中克隆了编码博马平(bomapin)的cDNA,它是丝氨酸蛋白酶抑制剂(serpin)超家族的成员之一(《生物化学杂志》270:2675,1995年)。为了解其在造血系统中的表达情况,我们对从正常供体以及白血病患者的骨髓或外周血中提取的RNA进行逆转录,并通过聚合酶链反应(PCR)进行分析。在正常骨髓中很容易检测到博马平PCR产物,其被定为中等mRNA水平。在外周血中,正常供体(n = 6)和慢性淋巴细胞白血病患者(n = 6)的博马平表达较低或无法检测到。慢性髓性白血病患者(n = 6)、慢性粒单核细胞白血病患者(n = 6)、急性髓性白血病患者(n = 5)和急性淋巴细胞白血病患者(n = 5)的血液中博马平表达水平为低到中等。此外,在一名急性单核细胞白血病患者中检测到高水平的博马平表达。这些数据表明,博马平在单核细胞系造血细胞中的表达可能会升高。因此,我们分析了博马平在具有单核细胞系特征的细胞系中的表达情况。在单核细胞系的THP - 1和AML - 193细胞系中检测到了博马平PCR产物,但在CRL 7607、CRL 7541、KG - 1或K562细胞中未检测到。在用佛波酯肉豆蔻酸酯(PMA,10(-8) mol/L)或肿瘤坏死因子 - α(TNF - α,30 U/mL)处理24小时后,在后者一系列细胞系中未检测到博马平转录本的诱导,而用这些试剂处理THP - 1或AML - 193细胞则降低了博马平PCR产物的强度。Northern印迹法证实了这些结果,并表明PMA在4天时间内下调了THP - 1细胞中博马平的表达,TNF - α的下调程度较小。免疫印迹法显示在THP - 1细胞溶质制剂中存在一种40 - kD的蛋白质。用PMA处理后,博马平抗原水平相应降低。由于PMA和TNF - α可诱导THP - 1和AML - 193细胞向单核细胞分化,这些数据增加了博马平可能在细胞分化早期阶段特异性调节蛋白酶活性中发挥作用的可能性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验